All In Biotech

Drug Trial Radar · NCT05305547

A Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19

A Phase 3, Multicenter, Randomized, Double-Blind, 24-Week Study of the Clinical and Antiviral Effect of S-217622 Compared With Placebo in Non-Hospitalized Participants With COVID-19

Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 2,093 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,093

Actual

Start

Aug 3, 2022

Primary completion

Jan 7, 2024

Study completion May 24, 2024

Sponsor

Lead sponsor
ShionogiIndustry
Sponsor type
Industry
Collaborators
National Institute of Allergy and Infectious Diseases (NIAID)
First posted
Mar 31, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main aim of this study is to evaluate the efficacy of S-217622 versus placebo among outpatient adults with mild and moderate COVID-19 starting intervention within 3 days of symptom onset.

Conditions

  • SARS-CoV-2 Infection

Interventions

  • S-217622Drug

    Administered as a round tablet.

  • PlaceboDrug

    Administered as a round tablet.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to Sustained Symptom ResolutionTime frame: Up to Day 29

Locations

196 sites in 17 countries. Site status is shown where the registry gives one.

  • Lakeview Clinical Research

    Guntersville, Alabama

  • Voyage Medical Services

    Tempe, Arizona

  • Novak Clinical Research

    Tucson, Arizona

  • Hope Clinical Research

    Canoga Park, California

  • Carbon Health

    Culver City, California

  • NICR

    Garden Grove, California

  • Ark Clinical Research (PARENT)

    Long Beach, California

  • UCSD Antiviral Research Center

    San Diego, California

  • University of California San Francisco (PARENT)

    San Francisco, California

  • Clinical Trials Management Services, 223 E. Thousand Oaks Blvd.

    Thousand Oaks, California

  • Lundquist Institute for BMI, UCLA Medical Center

    Torrance, California

  • University of Colorado Anschutz Medical Campus

    Aurora, Colorado

  • Whitman-Walker Health

    Washington D.C., District of Columbia

  • University of Florida Clinical & Translational Science Institute

    Gainesville, Florida

  • Universal Medical and Research Center

    Miami, Florida

  • CCR Medical Center, Suite 201

    Miami, Florida

  • Miami Clinical Research

    Miami, Florida

  • Vista Health Research, LLC

    Miami, Florida

  • Quantum Clinical Trials, 333 Arthur Godfrey Road, Suite 202, suite 208

    Miami Beach, Florida

  • Quality Research of South Florida

    Miami Lakes, Florida

  • Accel Research Sites Network, Ormond Clinical Research Unit, 77 West Granada Boulevard

    Ormond Beach, Florida

  • Clinical Research Center of Florida, 550 SW 3rd St.,, Suite #305

    Pompano Beach, Florida

  • Invictus Clinical Research Group, LLC

    Pompano Beach, Florida

  • Santos Research Center, CORP

    Tampa, Florida

  • Masters of Clinical Research

    Augusta, Georgia

  • Leavitt Clinical Research

    Idaho Falls, Idaho

  • Research Network America

    Berwyn, Illinois

  • Rush University Infectious Diseases

    Chicago, Illinois

  • Tandem Clinical Research

    Marrero, Louisiana

  • The Johns Hopkins Hospital

    Baltimore, Maryland

  • Infusion Associates

    Grand Rapids, Michigan

  • Revival Research Institute LLC

    Troy, Michigan

  • Las Vegas Medical Research

    Las Vegas, Nevada

  • AB Clinical Trials

    Las Vegas, Nevada

  • Renal Medicine Associates

    Albuquerque, New Mexico

  • Columbia University Irving Medical Center Division of Infectious Diseases

    New York, New York

  • NY Blood Center Project ACHIEVE

    New York, New York

  • University of Rochester Medical Center

    Rochester, New York

  • Lapis Clinical Research - North State

    Denver, North Carolina

  • Burke Primary Care

    Morgantown, North Carolina

Showing 40 of 196 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.